Stay updated on PDE4 Inhibition for Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the PDE4 Inhibition for Atopic Dermatitis Clinical Trial page.

Latest updates to the PDE4 Inhibition for Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe completed roflumilast trial record is displayed with its study details, eligibility criteria, outcome measures, locations, results history, and supporting documents.SummaryDifference69%

- Check13 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 while the study page remained on a 403 error screen.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA general NIH announcement about a terminology transition appears above the ClinicalTrials.gov error page. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe site's footer revision identifier changes from v3.7.0 to v3.7.1 while the study page displays a 403 Forbidden response.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record content; the site header/footer remain, but the main study details cannot be viewed.SummaryDifference18%

- Check62 days agoChange DetectedVersion tag updated from v3.6.6 to v3.7.0 to reflect the latest build of the page. No study content or functionality changes are introduced.SummaryDifference0.0%

Stay in the know with updates to PDE4 Inhibition for Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDE4 Inhibition for Atopic Dermatitis Clinical Trial page.